Steep Sell-Off Hits Mini Nuclear Reactor Developer, Wiping Out Nearly Two-Thirds of Share Value Overnight

NuScale Power, a pioneer in small modular reactor (SMR) technology, has experienced a significant downturn in its stock performance, with shares plummeting to below $13, a staggering 65% decline over the past 12 months. Despite this substantial drop, a closer examination of the company's underlying fundamentals reveals a complex landscape. On Thursday, NuScale Power Corporation's shares commenced trading at $12.05, fluctuating within a 52-week range of $8.85 to $57.42. The company's market capitalization stands at an impressive $4.4 to $4.5 billion, which seems disproportionate to its quarterly revenue of merely $565,000. This revenue figure not only fell short of Wall Street's projection of $7 million but also represented a drastic 95.8% year-over-year decline. The company's first-quarter operating deficit totaled $57 million, with earnings per share (EPS) of -$0.14, missing the consensus forecast of -$0.11. For the full year, NuScale is expected to report EPS of -$0.79.

On a more positive note, NuScale holds a unique position in the American nuclear reactor development landscape, being the only company to have obtained Nuclear Regulatory Commission certification for its SMR architecture. This certification sets NuScale apart from its competitors, such as Oklo and Nano Nuclear Energy, which may require several years to obtain similar approval. The company is currently engaged in two significant projects: a 462-megawatt facility in Romania and a 6-gigawatt SMR deployment in partnership with ENTRA1 for the Tennessee Valley Authority. Although these projects are expected to be completed beyond 2030, they demonstrate NuScale's potential for long-term growth.

Despite its substantial market valuation, NuScale operates essentially as a pre-commercialization enterprise, with a significant financial reserve of approximately $1 billion, including $341 million in cash and cash equivalents. However, this financial cushion has not yet translated to profitability. Recent insider transactions have raised some eyebrows, with company insiders selling over 40 million shares worth nearly $475 million in the past 90 days. The most notable transaction was by Director Corp Fluor, which sold 13.5 million shares in April at an average price of $11.81, totaling approximately $159 million. As a result, corporate insider ownership has dwindled to just 1.28% of total shares outstanding, while institutional investors maintain a dominant 78.37% stake.

The investment community's sentiment towards NuScale is mixed, with some analysts revising their price objectives downward. B. Riley reduced its target price from $24 to $19, while maintaining a "Buy" recommendation. HSBC initiated coverage with a "Hold" rating and a $13 target price. Royal Bank of Canada and TD Cowen also lowered their projections, with the latter downgrading the stock from "Buy" to "Hold" in February. The consensus view among 17 covering analysts is a "Hold" rating, with a mean price target of $15.92, representing a potential 25% upside from current trading levels. From a technical perspective, NuScale's stock is currently positioned between its 50-day moving average of $11.41 and its 200-day moving average of $15.38.